SCHEMBL2395500

SCHEMBL2395500

O=c1c(O)c(-c2ccc(OCc3ccccc3)cc2)oc2ccccc12

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 9/20 0.67
CYP3A4 P08684 8/20 0.67
MEN1 O00255 8/20 0.67
KMT2A Q03164 8/20 0.67
HSD17B10 Q99714 6/20 0.67
ALDH1A1 P00352 5/20 0.67
ALOX15 P16050 4/20 0.67
MAPK1 P28482 4/20 0.67
HPGD P15428 4/20 0.67
USP2 O75604 1/20 0.67
SMN1; SMN2 Q16637 1/20 0.67
FTO Q9C0B1 1/20 0.67
TP53 P04637 8/20 0.66
LMNA P02545 3/20 0.66
CA12 O43570 1/20 0.66
CA1 P00915 1/20 0.66
CA2 P00918 1/20 0.66
ABCB1 P08183 1/20 0.66
CALM1 P0DP23 1/20 0.66
AR P10275 1/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27325954 0.91 KDM4E (0.61) KDM4ECYP3A4MEN1KMT2AHSD17B10
SCHEMBL20169884 0.90 CYP3A4 (0.61) KDM4ECYP3A4MEN1KMT2AHSD17B10
SCHEMBL28565701 0.87 ABCG2 (0.69) KDM4EKMT2AHSD17B10ALDH1A1HPGD
SCHEMBL27491848 0.86 KDM4E (0.66) KDM4ECYP3A4MEN1KMT2AHSD17B10
SCHEMBL27325970 0.86 KDM4E (0.62) KDM4ECYP3A4MEN1KMT2AHSD17B10
SCHEMBL17523229 0.86 MAPT (0.61) KDM4ECYP3A4MEN1KMT2AHSD17B10
SCHEMBL2397393 0.84 MAPT (0.75) KDM4ECYP3A4MEN1KMT2AHSD17B10
SCHEMBL16151142 0.84 BCHE (0.56) KDM4ECYP3A4MEN1KMT2AHSD17B10
SCHEMBL10769734 0.84 ABCG2 (0.72) KDM4ECYP3A4MEN1KMT2AHSD17B10
SCHEMBL23259577 0.82 KDM4E (0.67) KDM4ECYP3A4MEN1KMT2AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8017649-B2 Flavonoid compounds and uses thereof HOWARD FLOREY INSTITUTE OF EXPERIMENTAL PHYSIOLOGY AND MEDICINE (AU) 2011-09-13 US disclosed
US-20090130051-A1 Flavonoid Compounds and Uses Thereof HOWARD FLOREY INSTITUTE OF EXPERIMENTAL PHYSIOLOGY AND MEDICINE (AU) 2009-05-21 US disclosed
EP-1856085-A1 FLAVONOID COMPOUNDS AND USES THEREOF Howard Florey Institute of Experimental Physiology and Medicine (AU) 2007-11-21 EP disclosed
WO-2006094357-A1 FLAVONOID COMPOUNDS AND USES THEREOF HOWARD FLOREY INSTITUTE OF EXPERIMENTAL PHYSIOLOGY AND MEDICINE (AU) 2006-09-14 WO disclosed
EP-0233105-A1 Therapeutical compositions based on 3-alkoxyflavone derivatives and derivatives of 3-alkoxyflavones INSTITUT PASTEUR (FR) 1987-08-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090130051-A1 Flavonoid Compounds and Uses Thereof CAT, NQO1, GPX4 KDM4E 4144/4885CYP3A4 518/4885MEN1 4830/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.